Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules
暂无分享,去创建一个
V. Cerundolo | M. Colonna | M. Cella | A. Exley | P. Dunbar | Margaret Jones | W. Gross | P. Bigliardi | S. Gadola | H. Moins-Teisserenc | S. Buechner | N. Blake | C. Baycal | J. Lambert | M. Willemsen | P. Dunbar | Hélène Moins-Teisserenc | Wolfgang L. Gross
[1] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. , 2010, Arthritis and rheumatism.
[2] J. Zimmer,et al. Inefficient protection of human TAP‐deficient fibroblasts from autologous NK cell‐mediated lysis by cytokines inducing HLA class I expression , 1999, European journal of immunology.
[3] A. Plebani,et al. HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. , 1999, The Journal of clinical investigation.
[4] K. Tadokoro,et al. Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome. , 1999, The Journal of clinical investigation.
[5] J. Zimmer,et al. Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome) , 1998, The Journal of experimental medicine.
[6] V. Cerundolo,et al. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway. , 1997, Immunology letters.
[7] M. Colonna. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors , 1997, Immunological reviews.
[8] L. Notarangelo,et al. Defective expression of HLA class I and CD1a molecules in boy with Marfan-like phenotype and deep skin ulcers. , 1996, Journal of the American Academy of Dermatology.
[9] J. Orange,et al. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. , 1996, Journal of immunology.
[10] L. Lanier,et al. Inhibitory MHC class I receptors on NK cells and T cells. , 1996, Immunology today.
[11] D. Roseeuw,et al. Unusual clinical manifestation of a disfiguring necrobiotic granulomatous disease. , 1995, Journal of the American Academy of Dermatology.
[12] J. Yewdell,et al. Assembly, Intracellular Localization, and Nucleotide Binding Properties of the Human Peptide Transporters TAP1 and TAP2 Expressed by Recombinant Vaccinia Viruses (*) , 1995, The Journal of Biological Chemistry.
[13] R. Porter. Nomenclature of Systemic Vasculitides: Proposal of an International Consensus Conference , 1995 .
[14] G. Ferrara,et al. NK3-specific natural killer cells are selectively inhibited by Bw4- positive HLA alleles with isoleucine 80 , 1994, The Journal of experimental medicine.
[15] J. Salamero,et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. , 1994, Science.
[16] R J Falk,et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.
[17] K. Ohnishi,et al. Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human blood monocytes by IFN-gamma and IL-4. , 1993, Journal of immunology.
[18] P. Cresswell,et al. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer , 1992, Nature.
[19] Shinichi Watanabe,et al. Immunohistochemical studies of major histocompatibility antigens in a case of the bare lymphocyte syndrome without immunodeficiency. , 1987, Journal of the American Academy of Dermatology.
[20] A. D. Kornblut,et al. Wegener's granulomatosis. , 1974, Otolaryngologic clinics of North America.
[21] R. Hertz,et al. WEGENER'S GRANULOMATOSIS. , 1963, The American journal of medicine.
[22] J. L. Fahey,et al. Wegener's granulomatosis. , 1954, The American journal of medicine.
[23] K. Tadokoro,et al. Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I). , 1999, Human immunology.
[24] Patricia Woo,et al. Oxford textbook of rheumatology , 1995 .
[25] B. Haynes,et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. , 1983, Annals of internal medicine.